Outset Medical, Inc.
OM
$3.53
$0.051.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.01% | 2.67% | 14.72% | 5.62% | -3.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.01% | 2.67% | 14.72% | 5.62% | -3.41% |
| Cost of Revenue | -10.86% | -5.33% | 11.05% | -4.88% | -17.63% |
| Gross Profit | 13.29% | 18.02% | 21.31% | 29.84% | 37.69% |
| SG&A Expenses | 2.47% | -13.69% | -23.92% | -29.05% | -21.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.85% | -13.83% | -16.97% | -25.70% | -23.58% |
| Operating Income | 13.81% | 33.67% | 45.18% | 51.68% | 41.26% |
| Income Before Tax | 24.36% | 37.19% | 46.25% | 35.48% | 33.38% |
| Income Tax Expenses | 2,475.00% | 121.98% | -31.13% | -29.01% | -103.57% |
| Earnings from Continuing Operations | 23.98% | 36.16% | 46.19% | 35.45% | 33.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.98% | 36.16% | 46.19% | 35.45% | 33.58% |
| EBIT | 13.81% | 33.67% | 45.18% | 51.68% | 41.26% |
| EBITDA | 12.07% | 34.06% | 46.37% | 53.49% | 42.93% |
| EPS Basic | 85.00% | 87.49% | 89.51% | 68.88% | 36.71% |
| Normalized Basic EPS | 84.21% | 87.70% | 89.53% | 76.45% | 35.78% |
| EPS Diluted | 85.00% | 87.49% | 89.51% | 68.88% | 36.71% |
| Normalized Diluted EPS | 84.21% | 87.70% | 89.53% | 76.45% | 35.78% |
| Average Basic Shares Outstanding | 406.73% | 410.42% | 413.10% | 107.43% | 4.95% |
| Average Diluted Shares Outstanding | 406.73% | 410.42% | 413.10% | 107.43% | 4.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |